Related Experiment Video
Updated: Jul 5, 2026

Early Viral Entry Assays for the Identification and Evaluation of Antiviral Compounds
Published on: October 29, 2015
Recent antiviral strategies against human coronavirus-related respiratory illnesses
1Microbiology Department, Faculty of Biochemistry Biophysics and Biotechnology, Jagiellonian University, Krakow, Poland.
Purpose Of Review:
The main purpose of this review is to summarize the current research (2006-2007) concerning the development of novel anticoronaviral strategies and compounds.
Recent Findings:
Recent research led to the identification of several novel agents inhibiting coronaviral replication. The most promising compounds include carbohydrate-binding agents, neutralizing antibodies and drugs targeting a coronaviral envelope protein.
Summary:
Although initial outbreaks of coronavirus that causes severe acute respiratory syndrome (SARS-CoV) were controlled by public health measures, the development of vaccines and antiviral agents for SARS-CoV is essential for improving control and treatment of future outbreaks. Four years after the SARS-CoV epidemic, several compounds with an anticoronaviral activity have been identified.
Related Concept Videos
Respiratory Syncytial Virus Disease
Antiviral Nucleoside Inhibitors
Inhibitors of Viral Protein Synthesis
Coronavirus
Inhibitors Of Virion Release
Human Virome

